ctrl K

Price Alert

ProQR Therapeutics N.V. (PRQR)

NASDAQ: PRQR · Real-Time Price · USD

2.04

0.02 (0.99%)

At close: Aug 15, 2025, 3:59 PM

2.05

0.24%

After-hours: Aug 15, 2025, 04:10 PM EDT

ProQR Therapeutics Balance Sheet Statement

Financials in EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	149.41M	118.92M	94.78M	187.52M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	621K	629K
Other Long-Term Assets	n/a	n/a	n/a	n/a
Receivables	2.03M	1.27M	57.24M	n/a
Inventory	n/a	n/a	6.87K	266.45K
Other Current Assets	n/a	n/a	n/a	n/a
Total Current Assets	153.84M	120.99M	154.46M	191.48M
Property-Plant & Equipment	14.11M	16.9M	16.24M	17.47M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	14.11M	16.9M	16.86M	18.1M
Total Assets	167.96M	137.88M	171.32M	209.58M
Account Payables	16K	1.54M	392K	191K
Deferred Revenue	21.94M	20.57M	5.76M	5.12M
Short-Term Debt	4.58M	n/a	2.5M	4.77M
Other Current Liabilities	9.32M	8.82M	9.95M	14.76M
Total Current Liabilities	38.9M	34.2M	21.11M	27.6M
Long-Term Debt	n/a	4.29M	4.27M	39.32M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	40.5M	62.29M	85.1M	68.75M
Total Liabilities	79.4M	96.49M	106.21M	96.35M
Total Debt	17.22M	19.73M	21.97M	60.37M
Common Stock	4.31M	3.37M	3.37M	3M
Retained Earnings	-427.16M	-400.85M	-380.68M	-317.77M
Comprehensive Income	27.6M	25.98M	30.26M	30.3M
Shareholders Equity	88.56M	41.39M	65.5M	113.83M
Total Investments	n/a	-98.05K	621K	629K